Drug intelligence / Profile preview

placental mesenchymal stem cell-derived exosomes

Development stage
Phase 3
Lead developer
Kimera Labs
Modality
Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
Administration
Topical, Inhalation, Intravenous, Intramuscular
01

Overview

Placental mesenchymal stem cell-derived exosomes are extracellular vesicles secreted by mesenchymal stem cells (MSCs) isolated from human placental tissue. These nano-sized vesicles function as cell-free therapeutic agents that encapsulate and transport a variety of bioactive molecules, including proteins, lipids, and specific microRNAs (such as hsa-let-7i-5p, miR-143, and miR-139-5p). They mediate intercellular communication and exert potent anti-inflammatory, antioxidant, anti-apoptotic, and pro-regenerative effects. By modulating critical signaling pathways—such as the NF-κB, MAPK, and PTEN/AKT pathways—these exosomes are being investigated for their ability to repair tissue damage in conditions like acute lung injury, intrauterine adhesions, chemotherapy-induced ovarian dysfunction, and spinal cord injury. They are also utilized in regenerative aesthetics for skin biostimulation and can serve as specialized drug delivery vehicles for natural compounds like berberine.

Other names
Human placental mesenchymal stem cell-derived exosomesPlacenta-derived mesenchymal stem cell exosomeshPMSC-derived exosomesPMSC exosomes

Beyond the preview

Go deeper on placental mesenchymal stem cell-derived exosomes.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on placental mesenchymal stem cell-derived exosomes.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call